Join the Clopidogrel group to help and get support from people like you.
Clopidogrel News
New Stroke Risk Down With Clopidogrel-Aspirin Initiated Within 72 Hours
THURSDAY, Dec. 28, 2023 – Combined clopidogrel-aspirin therapy initiated within 72 hours after stroke onset leads to lower risk for new stroke at 90 days among patients with mild ischemic stroke or...
P2Y₁₂ Inhibitor Monotherapy Better Than Aspirin in Coronary Artery Disease
MONDAY, July 10, 2023 – For patients with coronary artery disease (CAD), P2Y12 inhibitor monotherapy is associated with a lower risk for cardiovascular death, myocardial infarction, and stroke...
Ticagrelor-Acetylsalicylic Acid More Beneficial for Obese With Minor Stroke, TIA
MONDAY, July 10, 2023 – For patients with minor stroke or transient ischemic attack (TIA) who carry the CYP2C19 loss-of-function allele, those with obesity receive more clinical benefit from...
FDA Medwatch Alert: Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up
September 29, 2022, Golden State Medical Supply, Incorporated (GSMS, Inc.) - Camarillo, CA has initiated a voluntary recall of the products listed in the table below because a report was received...
FDA Medwatch Alert: Clopidogrel Tablets USP, 75 mg by International Laboratories: Recall - Product Mislabeling
ISSUE: International Laboratories, LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The...
FDA Medwatch Alert: Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
ISSUE: An FDA review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart...
FDA Medwatch Alert: Long-term Antiplatelet Therapy: Safety Announcement - Preliminary Trial Data Shows Benefits But a Higher Risk of Non-Cardiovascular Death
[Posted 11/16/2014] ISSUE: FDA is evaluating preliminary data from a clinical trial showing that treatment for 30 months with dual antiplatelet blood-thinning therapy decreased the risk of heart...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Ischemic Stroke, Myocardial Infarction, Heart Attack